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Abstract: Due to the limited regenerative capabilities of cardiomyocytes, incidents of myocardial
infarction can cause permanent damage to native myocardium through the formation of acellular,
non-conductive scar tissue during wound repair. The generation of scar tissue in the myocardium
compromises the biomechanical and electrical properties of the heart which can lead to further
cardiac problems including heart failure. Currently, patients suffering from cardiac failure due to
scarring undergo transplantation but limited donor availability and complications (i.e., rejection
or infectious pathogens) exclude many individuals from successful transplant. Polymeric tissue
engineering scaffolds provide an alternative approach to restore normal myocardium structure and
function after damage by acting as a provisional matrix to support cell attachment, infiltration and
stem cell delivery. However, issues associated with mechanical property mismatch and the limited
electrical conductivity of these constructs when compared to native myocardium reduces their clinical
applicability. Therefore, composite polymeric scaffolds with conductive reinforcement components
(i.e., metal, carbon, or conductive polymers) provide tunable mechanical and electroactive properties
to mimic the structure and function of natural myocardium in force transmission and electrical stim-
ulation. This review summarizes recent advancements in the design, synthesis, and implementation
of electroactive polymeric composites to better match the biomechanical and electrical properties of
myocardial tissue.
Keywords: composite; cardiac tissue; biomimetic; tissue engineering; conductive
1. Introduction
Myocardial infarction (MI) or heart attack occurs when the delivery of oxygen and
other nutrients to cardiac muscle cells is hindered, causing myocardial cell death [1]. Since
cardiomyocytes have poor regenerative capabilities, damage from heart attack incidents
for survivors often leads to the permanent development of acellular, relatively stiff, and
non-contractile scar tissue [2]. Loss of myocardial tissue structure and electromechanical
function in the damaged region can lead to progressive heart failure and even death. In
the United States, there are approximately 805,000 MI incidents a year, 25% of which are
repeat MI events for patients [3]. Therefore, many conventional treatment approaches have
been developed to either prevent recurrent MI events or restore the mechanical function
of the heart while there are little to no options aimed at reverting or repairing damaged
myocardium. For example, many pharmaceuticals focus on suppressing future MI events
by targeting pathways involved in coronary artery disease, thrombosis of cardiac arteries,
or other pathologies that limit the adequate flow of nutrients to heart muscle tissue [1].
Additionally, left ventricular assist devices have been successfully implemented to assist
in the mechanical function (i.e., blood pumping) of a failing, damaged heart but this
approach has many potential drawbacks such as reducing patient mobility, producing
thrombus or embolus in device tubing, and increasing the potential for infection due to
the transcutaneous power supply port on the device [4]. A heart transplant procedure is
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often the last option for a patient with heart failure and limited donor numbers as well
as the potential for graft rejection excludes many individuals from receiving a successful
transplant [5].
To address the limitations of conventional treatments for scarred heart tissue, alter-
native approaches for restoring damaged heart function have been developed including
stem cell delivery therapies [6]. The principle behind stem cell treatments for cardiac
tissue repair includes the injection of patient derived or donor mesenchymal stem cells
into the ischemic area of the heart so they can differentiate into cardiomyocytes and be-
come electrically and mechanically coupled to healthy cells in the heart, repairing the
damaged region [7]. Limited stem cell survival and the fact that injected stem cells often
do not remain in the damaged area of the heart have restricted the effectiveness of this
treatment method [8]. Therefore, researchers have designed cardiac scaffolds composed of
decellularized extracellular matrix (ECM) and synthetic polymers to aid in the retention
and differentiation of stem cells for myocardium repair by acting as a provisional matrix
to support cell attachment and infiltration [5,9]. Since these scaffolds are composed of
provisional matrix components (i.e., fibrin, collagen, etc.) or synthetic polymers (i.e., poly-
caprolactone, polyglycercol sebacate, etc.), they often do not match the properties of the
native myocardium with respect to modulus (0.02–0.5 MPa) and conductivity (5 × 10−5–
1.6 × 10−3 S/cm), causing limited electromechanical coupling among cells seeded on the
scaffolds [10,11]. Failing to emulate the electromechanical conditions of the natural my-
ocardium microenvironment reduces the effectiveness of this approach because myocardial
substrate stiffness and electrical stimulation play a vital role in modulating the differen-
tiation, function, and proliferation of myocardiocytes [12–15]. As a result, scientists and
engineers are developing electroactive polymeric composite materials for cardiac scaffolds
to mimic native myocardium electromechanical properties [16]. In this review, the recent
advancements in the design, synthesis, and implementation of electroactive polymeric
composites to better match the biomechanical and electrical properties of myocardial tissue
will be summarized. The additional functions of polymeric composites in cardiac tissue re-
pair such as therapeutic delivery, antimicrobial effects, and adhesive element incorporation
are also highlighted for relevant examples.
2. A Composite Approach to Biomimicry for Cardiac Tissue Engineering
Composites are created by combining two or more materials to achieve a hybrid
structure with the chemical and physical qualities of each constituent [17]. More specifically,
composites have a matrix phase and one or more reinforcement phases. The matrix
phase is generally softer, present in larger volumetric quantities, and contributes to bulk
the mechanical properties of the composite [18]. Conversely, reinforcement phases are
generally stiffer, present in less volumetric quantities, and can supplement the properties
of the matrix phase (i.e., increase material toughness, conductivity, etc.) [18]. There are
two major subsets of composite materials: natural and synthetic composites. Common
examples of natural composites include wood and bone while materials like carbon fiber
reinforced epoxy/nylon and fiberglass are considered synthetic composites.
Muscle, including myocardial tissue, can also be considered a composite structure
since it contains various proteins, fibers, connective tissue, water, nerves, blood vessels, and
cells [17]. It is also important to note that muscle tissue presents composite structures at
micro and nano hierarchical scales and is anisotropic with respect to its mechanical and elec-
trical properties. Scarred myocardial tissue does not contain all of the constituents present
in normal muscle composite tissue and has compromised electromechanical properties
(Figure 1A). Therefore, to restore some aspects of the composite structure of damaged mus-
cle tissue while mimicking the proper electromechanical cues, conductive polymer-based
composites are being developed. These constructs mimic native cardiac muscle modulus
and conductivity by combining a polymeric matrix phase and one or more conductive
reinforcement phases (Figure 1B). The polymeric matrix phase can include either natural or
synthetic polymers that emulate the stiffness of normal myocardium while the conductive
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reinforcement phase can contain metallic, carbon, or conductive polymer constituents to
give the composite structure a conductivity that matches that of healthy myocardium.
During or after the synthesis of composite scaffolds, host or donor myocardiocytes or
precursors of myocardiocytes (i.e., mesenchymal stem cells) can be mixed with or seeded
onto the composites whereafter cyclic electromechanical stimulation can be applied to
emulate the normal myocardial microenvironment and constructs can be implanted or
injected into the ischemic areas of damaged myocardial tissue (Figure 1C).
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Figure 1. Healthy heart tissue contains myocardiocytes, has a modulus from 0.02 to 0.5MPa, and is electrically active
(A-i.), whereas heart tissue affected by myocardial infarction (MI) is acellular, scar-like, with an increased modulus, and
not electrically active (A-ii.). Conductive composites for cardiac tissue engineering are generated by combining natural
or synthetic polymers such as chitosan or polyacrylamide (B-i.) with conductive elements that are metallic-, carbon-, or
polymeric-based such as gold nanoparticles, graphene, or polyaniline (B-ii.). These electrically active composites act as a
synthetic myocardial extracellular matrix (ECM) by mimicking the electromechanical properties of native myocardium and
can be seeded with host, donor, or precursors of myocardiocytes (i.e., mesenchymal stem cells) for cardiac tissue repair (C).
There are many advantages of using conductive composite materials to mimic normal
electromechanical properties of the myocardium for cardiac repair and in cardiac in vitro
model systems [16]. For example, the conductivity of the composite can be easily tailored
by varying the concentration of the conductive reinforcement constituent. Additionally, by
altering the crosslinking density of the polymeric matrix phase and/or the concentration
of the reinforcement phase, the bulk mechanical properties (i.e., stiffness) of the composite
scaffolds can be tuned to better match that of native myocardium. Some reinforcements,
such as fibers, can even mimic the anisotropic organization and direction-dependent
mechanical and electrical properties of muscle tissue [17]. With a composite approach to
biomimicry, it is also possible to include additional constituents that can act as cell and
drug delivery vehicles, provide antimicrobial features, or supply adhesive properties which
enables conductive polymeric composites that mimic the electromechanical aspects of the
myocardium to further augment cardiac tissue repair and regeneration in vivo.
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3. Reinforcement Methods to Mimic the Electromechanical Properties of Myocardium
with Polymeric Composites
3.1. Overview of Conductive Reinforcement Types
Composite reinforcement phases can be generated in many forms (i.e., particles, fibers,
etc.), sizes (i.e., micro or nano scale), and types (i.e., metallic, carbon, and conductive
polymer-based reinforcement) to create electrically active scaffolds for cardiac tissue re-
pair. Each reinforcement technique has distinct advantages and disadvantages that will
be described with examples in subsequent sections. An overview of different types of
reinforcement techniques for conductive composites in cardiac tissue engineering and their
associated conductivity and elastic modulus are listed here (Table 1). The targeted proper-
ties of the composites aim to match that of native myocardial modulus (0.02–0.5 MPa) and
conductivity (5 × 10−5–1.6 × 10−3 S/cm) [10,11]. The specific examples of electroactive
polymeric composites reviewed were chosen on the basis that they showed successful
implementation with in vitro studies.







Metallic-Based Chitosan/gold nanoparticle (CS-GNP) hydrogels 8–13 6.1 × 10
3–
6.8 × 103 [19]
Nylon/molybdenum disulfide (MoS2)
nanosheets 20 × 10
−6 3 × 106 [20]
Gold nanoparticles in thiol-HEMA/HEMA
scaffolds 1060–1530 0.6 × 10
6 [21]
Collagen–silver/gold nanoparticle matrices 0.75 × 10−4 N/A [22]
Carbon-Based Reduced graphene oxide/polyacrylamider(GO/PAAm) hydrogel 1.3 × 10
−4 50 × 103 [23]
Doped carbon nanofibers in chitosan 4 28.1 × 103 [24]
Graphene oxide/chitosan (GO/CS) scaffolds 13.4 N/A [25]
Polyvinyl alcohol/chitosan/carbon nanofibers
(PVA-CS-CNT) 3.4 × 10
−6 130 × 106 [26]
Reduced graphene oxide-silver (rGO-Ag)
nanocomposites in polyurethane (PU) nanofibers 100 × 10
−6 210 × 106 [27]
Chitosan/dopamine/graphene oxide




Polyaniline (PANI) -poly(glycerol-sebacate) (PGS)
composite doped with camphorsulfonic acid 0.018 6 × 10
6 [10]
Acid-modified silk fibroin–poly (pyrrole) (AMSF
+ PPy) substrates 1 7 × 10






142.7 × 103 [11]
Nitric oxide inducing tetraaniline-polyethylene
glycol diacrylate (TA-PEG) and thiolated
hyaluronic acid (HA-SH) hydrogel
2.32 × 10−4 23 [30]
3i-1000 loaded poly(glycerol sebacate)
(PGS)/collagen/ carbonized porous silicon
nanoparticle composites
0.06 0.08 × 106 [31]
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3.2. Metallic-Based Reinforcement
Metallic-based reinforcement in polymeric composites most often occurs in the form
of particles, fibers, or sheets. Most metals used in these composite constructs (i.e., gold,
silver, and molybdenum) are generally inert, resistant to corrosion, and have very high
conductive properties [32]. Additionally, metals can be easily conjugated with antibodies,
ligands, or drugs to further promote myocardial tissue regeneration [32]. The amount of
the metallic reinforcement constituent in a composite construct has to be tightly controlled
though as high concentrations of relatively hard metallics can cause undesired increases
in mechanical properties (i.e., stiffness, strength) which can lead to contact damage at the
interface of the construct and eccentric host tissue cyclic mechanical loading with heart
contractions [33].
One example of using metallic reinforcement in a composite structure for cardiac tis-
sue repair includes chitosan/gold nanoparticle (CS-GNP) hydrogels [19]. These constructs
were synthesized by combining chitosan, gold nanoparticles, and β-glycerophosphate
(β-GP) while the gold nanoparticles were reduced with a sodium citrate solution
(Figure 2A). More specifically, electrostatic interactions between chitosan and β-GP as
well as hydrophobic and hydrogen bonding between chitosan chains enabled the gelation
of the hydrogel structure. With this approach, Baei et al. was able to show that hydrogels
could be generated with a range in stiffness (6.1 × 103–6.8 × 103 Pa) and conductivity
(8–13 S/cm) by varying the concentration of gold nanoparticles (Figure 2B). Even with
the stiffness of these constructs being slightly less than that of normal myocardium and
the conductivity of the composite being much higher than healthy myocardium, markers
for the differentiation of mesenchymal stem cells into cardiomyocytes (Nkx-2.5 transcrip-
tion factor and alpha myosin heavy chain; α-MHC) were significantly higher in samples
containing gold nanoparticles (35% Nkx-2.5 and 25% α-MHC positive cells) than pure chi-
tosan hydrogel controls (19% Nkx-2.5 and 9% α-MHC positive cells) (Figure 2C). Another
metallic reinforcement example includes thiol-HEMA/HEMA scaffolds that contain gold
nanoparticles [21]. These scaffolds were synthesized with photopolymerization and were
designed to include micropores that could facilitate cell infiltration. With these constructs,
the modulus (0.6 MPa) matched that of normal myocardium very closely and Western blot-
ting showed that rat cardiomyocytes electrically stimulated on the conductive composites
had a twofold increase in the expression of connexin-43, a protein that modulates current
flow through cardiomyocytes, when compared to cells seeded on non-stimulated scaffolds,
indicating that cells were better electrically coupled.
In addition to gold nanoparticles, silver nanoparticles are excellent conductors and
inherently antimicrobial, limiting the adhesion and proliferation of harmful bacteria such
as Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia
coli [34]. In one study, silver nanoparticles were suspended in collagen gels to improve the
overall conductivity of the material for cardiac repair applications [22]. Neonatal cardiomy-
ocytes electrically stimulated for 24 h on collagen matrices with silver nanoparticles had a
two-fold increase of connexin-43 levels when compared to samples that did not contain
silver nanoparticles which demonstrates that cells seeded and electrically stimulated on
collagen matrices with silver nanoparticles were better electrically coupled. Furthermore,
these same gels promoted two times the amount of macrophage infiltration of the M2
phenotype than unpolarized (M0) and M1 phenotype macrophages which indicates that
the scaffolds elicited more of a wound healing response rather than an inflammatory
one. Another recent metallic reinforced composite for myocardium repair includes ny-
lon/molybdenum disulfide (MoS2) nanosheets [20]. These scaffolds exhibited a modulus
of 3 × 106 Pa and a conductivity of 20 × 10−6 S/cm which are physiologically relevant to
myocardial tissue. With real-time PCR, it was found that mouse embryonic cardiac cells
seeded on nylon/MoS2 sheets expressed significantly higher gene markers of myocardio-
genic differentiation (200 times more cardiac muscle troponin and 100 times more alpha
myosin heavy chain) when compared to nylon only sheets.
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(* p < 0.05) (C). (CS, CS-1GNP, CS-2GNP, and CS-3GNP indicates 0, 0.5, 1, and 1.5 GNP/CS % w/w,
respectively) [19].
3.3. Carbon-Based Reinforcement
Carbo -based re nforcement for conductive polymeric comp sites can be inco porated
in the form of fibers, sheets, r arbon n otubes (CNT). Th advantages of t is type
f reinforcement includ the fact that carbon materials (i.e., CNTs, graphene, graphene
oxide, an reduced graphene oxide) n provide adequate thermal, mechani l, and
electrical properties a well s a wide range of structural diver ity for cardiac regeneration
pplicati ns [35]. How ver, CNTs a d impurities in graphene materials have shown limited
biocompatibility, but the purity, size, concentration, and hydrophilicity of hese materials
can be adjust d to limit adver e toxicol gical affects and improve cell viability [36,37].
Graphene-bas d aterials can be used in many m dical field applications (i.e., bioimaging,
tissue engi eering, drug delivery, biosensing, etc.) as their structure can be altered to
exhibit geometry in 0, 1, 2, or 3 dimensions [37]. Further modification of graphene via
oxidation forms a graphene oxide (GO) material that is amphipathic and more easily
hydrated co pared to graphene, but the conductivity of graphene is greatly diminished
when oxidized [37]. Therefore, researchers have used reducing agents to generate reduced
graphene oxide (rGO) which partially restores the electrical properties of the original
graphene material [37].
One example of using carbon-based reinforcement in composites for cardiac tissue
engineering includes doped carbon nanofibers in chitosan [24]. These porous scaffolds
were prepared through the precipitation of carbon fibers in a chitosan matrix. Carbon
fiber reinforcement contributed to the relatively high conductive properties for the com-
posite material (4 S/cm) while the chitosan matrix phase influenced the bulk mechanical
properties of the material. Additionally, chitosan is inherently anti-oxidative and therefore
can aid in reducing the amount of potentially damaging reactive oxygen species near
scarred areas of the heart [19]. The overall stiffness of the chitosan scaffold was significantly
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increased with the addition of carbon nanofibers since chitosan only constructs exhibited
a stiffness of 17.8 × 103 Pa whereas carbon fiber reinforced chitosan had a modulus of
28.1 × 103 Pa. Neonatal rat cardiomyocytes seeded on chitosan scaffolds with and without
carbon nanofibers for 14 days exhibited significantly higher gene expression (4 fold increase
in atrial natriuretic factor, 5.5 fold increase in α-myosin heavy chain, 4.5 fold increase in
β-myosin heavy chain and a 2.5 fold increase in gata binding protein) of cardiomyocyte
markers involved in cell contraction and the propagation of electrical signals on scaffolds
containing carbon nanofibers when compared to chitosan only controls. These results indi-
cate that cells seeded on the carbon nanofiber/chitosan scaffolds were better electrically
and mechanically coupled than cells on chitosan only constructs.
Carbon-based reinforcement in the form of graphene sheets was also used in poly-
meric composite materials for muscle tissue repair by creating a reduced graphene ox-
ide/polyacrylamide r (GO/PAAm) hydrogel. This construct was synthesized by crosslink-
ing acrylamide with bisacrylamide in the presence of a graphene oxide solution whereafter
the graphene oxide construct was reduced in L-ascorbic acid [23] (Figure 3A). The average
stiffness of these hydrogels (50 × 103 Pa) was lower than that of native myocardium, but the
conductivity of the reduced graphene oxide/polyacrylamide scaffolds (1.3 × 10−4 S/cm)
fell within the range of normal myocardium and was significantly higher than non-reduced
graphene oxide/polyacrylamide (4.0 × 10−5 S/cm) and polyacrylamide (1.6 × 10−5 S/cm)
constructs (Figure 3B). To evaluate the ability of the hydrogels to promote myocardiocyte
differentiation with electrical stimulation, mouse myoblasts were seeded on constructs and
stimulated (5 V at 1 Hz for 4 h/day) for 3 or 7 days. Real-time PCR results indicated that
the gene expression of myogenic markers (myoblast determination protein 1, myogenin,
and alpha myosin heavy chain) were significantly higher for electrically stimulated scaf-
folds that were reduced for 24 h when compared to unstimulated scaffolds after 7 days
(Figure 3C). These results indicated that the conducive aspect of the composite hydrogels
could improve myocardiocyte differentiation.
A mussel-inspired carbon-reinforced composite hydrogel composed of chitosan/
dopamine/graphene oxide (CS-DA-GO) enabled supplemental functionality to the con-
struct by providing self-healing and adhesivity abilities in addition to mimicking the
electromechanical properties of normal myocardium [28]. This hydrogel formulation was
able to generate scaffolds with a range of conductivity based on the concentration of GO.
For example, constructs with 0 mg/mL of GO had a conductivity of 0.57 × 10−3 S/cm
whereas constructs with 1 mg/mL of GO had a higher conductivity of 1.22 × 10−3 S/cm.
In addition, the inclusion of dopamine in the structure amplifies the composite adhesive
and self-healing abilities. There are numerous advantages of having an adhesive struc-
ture in composite materials for cardiac tissue engineering including better host/scaffold
electromechanical integration and improved ease of application in clinical settings. The
adhesive character of the composite hydrogels could also be increased by altering the
concentration of GO since the researchers noted that adhesive strength increased from
0.15 MPa to 0.95 MPa with GO content until a concentration of 0.5 mg/mL of GO was
reached, whereafter adhesive strength started to decrease. Additionally, when hydrogels
were transected and tested in compression, stress–strain curve results indicated that self-
healed hydrogels showed a 91% recovery rate when compared to undamaged scaffolds.
When evaluating the in vitro spontaneous beating rate of myocardiocytes seeded on chi-
tosan/dopamine/graphene oxide hydrogels, it was found that cells were able to beat at a
rate (54 times per minute on constructs that contained 0.5 mg/mL GO) similar to a normal
human resting heart (60 beats per minute).
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3.4. Conductive Polymer-Based Reinforcement
Some polymers are inherently conductive, such as polyaniline (PANi), polypyrrole
(PPy), or poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT: PSS) and there-
fore can be incorporated into polymer blends or copolymers to generate polymeric rein-
forced composites [38]. Advantages of using conductive polymers for composite material
reinforcement include that they exhibit excellent biocompatibility and mimic the mechani-
cal properties (i.e., stiffness) of native myocardium [38]. Additionally, polymeric reinforced
composites can be easily loaded with therapeutic agents (i.e., growth factors or angio-
genic molecules) to improve outcomes of cardiac tissue repair. However, some conductive
polymers have limited solubility and are subject to oxidative degradation under environ-
mental service conditions making it more difficult to maintain electrical conductivity over
time [10].
One example of a conductive polymer reinforced composite for cardiac tissue repair
includes a gelatin/aniline pentamer-glutathione (Gel/AP-GSH) hydrogel [11]. These con-
structs were generated by mixing gelatin and aniline pentamer-glutathione which was
subsequently crosslinked with a glutaraldehyde solution (Figure 4A). Field Emission Scan-
ning Electron Microscope (FESEM) imaging showed that scaffolds composed of different
weight/volume % AP-GSH all contained a porous microstructure which allowed for easier
cardiomyocyte infiltration (Figure 4B). By varying the concentration of AP-GSH, a range of
physiologically relevant hydrogel stiffness (55.1 × 103–142.7 × 103 Pa) and conductivity
(3.4 × 10−5–1.0 × 10−4 S/cm) could be generated (Figure 4C-D). Since glutathione (GSH)
is an antioxidant, this construct also has the potential to reduce local concentrations of
reactive oxygen species which could help in improving cardiac tissue repair outcomes.
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Immunofluorescence results showed the amount of α-actinin, a myocardiocyte differenti-
ation marker, and connexin 43 (Cx-43), an indicator of cardiomyocyte electromechanical
coupling, present in rat adipose stem cells seeded on constructs for 7 days was directly
dependent on the concentration of AP-GSH in the composite material. Therefore, this
result shows that increasing the percentage of the conductive constituent (AP-GSH) in this
composite material facilitated the transition of stem cells to a myocardiocyte phenotype.




Figure 4. The synthesis of gelatin/aniline pentamer-glutathione composite (Gel/AP-GSH) porous 
scaffolds (A). FESEM images of different w/v% AP-GSH porous scaffolds which allow for better 
cardiomyocyte infiltration (B). The modulus and conductivity of scaffolds containing different 
concentrations of AP-GSH (C–D) (* p < 0.05 vs. Gel scaffold and # p < 0.05 vs. Gel/AP-GSH 6.25). 
(Gel = gelatin, Gel/CCAP = gelatin/carboxyl-capped aniline pentamer, and Gel/AP-GSH = gela-
tin/aniline pentamer-glutathione) [11].  
4. Future Outlook 
Despite promising in vitro study results with electroactive polymeric composites for 
cardiac tissue repair, there are still some critical barriers to the implementation of these 
materials in vivo. The largest challenge to implementing these composite materials in vivo 
is graft-host electromechanical integration [40]. Therefore, the field is transitioning to de-
signing conductive cardiac scaffolds that are injectable, adhesive, and able to cure in situ 
for better electromechanical interfacing with patient heart tissue without the need for su-
tures [41,42]. There are many advantages to an adhesive composite material including the 
fact that sutures create stress concentration and cause damage to otherwise healthy myo-
cardium whereas injectable adhesive materials can adhere and conform to patient-specific 
geometry in the cardiac tissue microenvironment [41,42]. Some examples of recently de-
veloped electrically conductive composite scaffolds that are inherently adhesive include 
polyaniline-grafted quaternized chitosan and poly(1-pyrenemethyl methacrylate-co-do-
pamine methacrylamide) [43]. In addition to generating adhesive scaffolds, more in vivo 
animal studies need to be performed to evaluate the safety and efficacy of composite con-
structs for repair of scarred myocardium. To further advance the field, improvements in 
micro and nano technologies have also started to be applied to electroactive polymeric 
composite materials so that they can mimic the topographical cues present in normal my-
ocardium [44]. Drawing upon developments in other fields related to electrically active 
tissues (i.e., neuronal tissue) could also potentially help advance the design and develop-





Figure 4. The synthesis of gelatin/aniline pentamer-glutathione composite (Gel/AP-GSH) porous
scaffolds (A). FESEM images of different w/v% AP-GSH porous scaffolds which allow for bet-
ter cardiomyocyte infiltration (B). The modulus and conductivity of scaffolds containing differ-
ent concentrations of AP-GSH (C,D) (* p < 0.05 vs. Gel scaffold and # p < 0.05 vs. Gel/AP-
GSH 6.25). (Gel = gelatin, Gel/CCAP = gelatin/carboxyl-capped aniline pentamer, and Gel/AP-
GSH = gelatin/aniline pentamer-glutathione) [11].
Poly(glycerol sebacate) (PGS)/collagen/polypyrrole (PPy) hydrogels which incor-
porate carbonized porous silicon nanoparticles loaded with 3i-1000, a small molecule
inhibitor of cardiomyocyte hypertrophy, provide another example of a conductive polymer
reinforced composite that could accelerate cardiac tissue repair [31,39]. The PGS compo-
nent enables the composite to have a stiffness (0.08 × 106 Pa) similar to that of native
myocardium while the collagen constituent allowed for cell adhesion. Additionally, the
researchers could tune the conductivity of the composite material from 0 to 0.06 S/cm
by varying the volume percent of PPy from 0% to 5%. Thr ugh the release of 3i-1000
from silicon nanoparticles, these comp site hydrogels were als sho n to promote car-
diomyoblast cell proliferation while inhibiting hypertrophic myocardiocyte respon es often
associated with MI. Another innovative p lymeric-based reinforced comp sit includes a
t traaniline-polyethylene glycol diacrylate (TA-PEG) nd th olated h aluron c acid (HA-
SH) hydrogel that incorporates plasmid enco ing endothelial nitric oxide synth s (eNOS)
nanoparticles [30]. The conductivity of these co structs could be altered fro 7.08 × 10−8
to 2.32 × 10−4 S/cm by varying TA-PEG volumetric concentration from 0% to 7.5% which
indicates that these hyd ogels c uld match the electrical properti s of natural myocardium.
In vitro studies were als able to show that th gene ncoding eNOS nanoparticles enabled
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the composite to induce the production of endogenous nitric oxide, a known stimulator of
angiogenesis, by a factor of 5 in adipose derived stem cells when compared to untreated
controls which is significant because scarred myocardium lacks adequate vasculature and
therefore has limited blood supply.
4. Future Outlook
Despite promising in vitro study results with electroactive polymeric composites for
cardiac tissue repair, there are still some critical barriers to the implementation of these
materials in vivo. The largest challenge to implementing these composite materials in vivo
is graft-host electromechanical integration [40]. Therefore, the field is transitioning to
designing conductive cardiac scaffolds that are injectable, adhesive, and able to cure in
situ for better electromechanical interfacing with patient heart tissue without the need for
sutures [41,42]. There are many advantages to an adhesive composite material including
the fact that sutures create stress concentration and cause damage to otherwise healthy
myocardium whereas injectable adhesive materials can adhere and conform to patient-
specific geometry in the cardiac tissue microenvironment [41,42]. Some examples of
recently developed electrically conductive composite scaffolds that are inherently adhesive
include polyaniline-grafted quaternized chitosan and poly(1-pyrenemethyl methacrylate-
co-dopamine methacrylamide) [43]. In addition to generating adhesive scaffolds, more
in vivo animal studies need to be performed to evaluate the safety and efficacy of composite
constructs for repair of scarred myocardium. To further advance the field, improvements
in micro and nano technologies have also started to be applied to electroactive polymeric
composite materials so that they can mimic the topographical cues present in normal
myocardium [44]. Drawing upon developments in other fields related to electrically
active tissues (i.e., neuronal tissue) could also potentially help advance the design and
development of composite materials used in cardiac tissue engineering.
5. Summary
In summary, electroactive polymeric composite materials can be utilized to improve
the outcomes of stem cell therapies in cardiac tissue repair. The electromechanical prop-
erties of these composites can be tuned to mimic myocardial ECM for cardiac tissue
engineering scaffold and in vitro model system applications. To alter the electromechanical
properties of composite materials, different types of conductive reinforcement (i.e., metallic,
carbon, or conductive polymer) can be utilized. Since composite materials can incorpo-
rate many constituents, there is also potential for these constructs to provide additional
functionality outside of mimicking electromechanical properties of heart tissue including
aiding in the therapeutic delivery of drug and cells, providing antimicrobial features, and
being adhesive. Overall, using different types of electroactive polymeric composites offers
a unique approach to advancing stem cell therapies in cardiac tissue repair applications,
but there are still many tests to be performed and improvements to implement in the field
before these materials can potentially be utilized in the clinic.
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